Micro
Emerging
Active
AZN FDA approval for PTEN-deficient metastatic prostate cancer
New narrative with limited coverage — still forming.
Score
0.4
Velocity
▲ 0.0
Articles
2
Sources
1
Sentiment Timeline
Event Timeline
Timeline
Last UpdatedJun 13, 2026